This report was recently updated on April 16 2024 with the latest and most recent
market numbers
Global Orphan Drugs Market Size, Trends & Analysis - Forecasts to 2028 By Drug Type (Biological and Non-Biological), By Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, and Others), By Therapy Class (Oncology, Hematology, Neurology, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, and Others) and By Region (North America, Asia Pacific, South America, Europe, and the Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis
The global orphan drugs market is expected to grow from USD 201.5 Billion in 2023 to 454.8 Billion by 2028 and is projected to grow at a CAGR of 14.5% from 2023 to 2028.
An orphan drug is a pharmaceutical product that is used to treat rare disorders. An orphan drug is produced in order to target a small group of patients in the overall drugs market. This requires fewer marketing and advertising process since the targeted patients come under a smaller scale as compared other disease segments.
Most rare diseases are genetic in nature and are associated with the patient for the rest of their lives. Orphan drugs are used to treat these types of rare diseases which occur due to changes in the genes. In the report shared by the national institute of health (NIH) in 2020, there were an estimated 7000 rare diseases in the U.S., and approximately 25-30 million Americans are living with rare diseases. Because of the rising prevalence, the series of manufacturing FDA approved orphan drugs is increasing rapidly.
The favorable government guidelines for orphan drugs is expected to boost the market. Furthermore, the increasing prevalence of rare diseases and high treatment costs per patient fuels the global orphan drugs market. In addition, increasing cancer and genetic diseases drive the growth of the market. Moreover, increasing awareness about the benefits of orphan drugs and increasing investment in R&D initiatives are expected to act as growth-inducing factors for the orphan drugs market.
The requirement for rare diseases medicine and the availability of a market exclusively for drugs manufacturers is creating opportunities in the global orphan drugs market. The government policies and subsidiaries for rare disease medicine help emerging drugs manufacturers. In addition, extensive spending on research and development helps orphan drugs development.
The biological segment is expected to be the fastest-growing segment in the market from 2023-2028. The presence of a platform and feature of delivery is the major growth factor of the biological segment, and because of that, this segment holds the largest share of the market. The food and drug administration (FDA) of the U.S., has developed over 600 orphan drugs and their designation.
The oncologic diseases segment holds the largest share of the global orphan drugs market and is anticipated to be the fastest-growing segment in the market from 2023-2028. The oncologic disease is the most common disease among all and it is classified into pancreatic cancer, ovarian cancer, and others. Metabolic diseases are related to the processing of food into energy. Hematologic diseases are related to blood and blood-producing organs which are most common in the U.S.
The oncology segment holds the largest share of the global orphan drugs market and is anticipated to be the fastest-growing segment in the market from 2023-2028. The key players in the market are focusing on the production of oncology drugs and a large number of oncology drugs are used in the treatment of cancer. The hematology segment is the second most dominating segment because hematology products are increasing rapidly with fast positive regulatory approvals.
The online sales segment is expected to be the fastest-growing segment in the market from 2023-2028. In online sales, consumers can easily purchase a drug with their mobile or laptop devices which provides the best purchase experience. Hospital pharmacy holds the largest share of the market. In hospital pharmacy, drugs are provided by a trained healthcare professional. Retail pharmacy is expected to remain stable in the forecast period.
Geographically, the market is anticipated to remain stable in North America due to rising cases of rare diseases, better reimbursement policies, and a strong patient population. This region holds the largest share of the global orphan drugs market.
Asia Pacific is growing rapidly due to the competitive landscape. The growing healthcare infrastructure and increasing awareness about the disease is the major growth factor for this region.
The European orphan drugs market is dominated by France, Belgium, Italy, Germany, and United Kingdom. The presence of a strong patient population and the adoption of new drugs therapies are helping to register better CAGR in this region.
The key players covered in the global orphan drugs market are Amgen Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Alexion Pharmaceutical Inc., Novo Nordisk A/S, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca, Daiichi Sankyo Company, and GlaxoSmithKline plc, among others.
Please note: This is not an exhaustive list of companies profiled in the report.
Chapter 1 Research Methodology
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GME’s Internal Database
1.3.3 Primary Research
1.3.4 Secondary Sources & Third-Party Perspectives
1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website
1.3.4.2 Secondary Data Sources: World Health Organization, Laboratory Corporation of America Holdings, IQVIA, Syneos Health
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Therapy Class & Data Visualization
1.6 Data Validation & Publishing
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Top-Down Approach
1.7.1.2 Bottom-Up Approach
1.8 Market Segmentation & Scope
1.9 Market Definition
Chapter 2 Executive Summary
2.1. Global Market Outlook
2.2 Drug Type Outlook
2.3 Disease Type Outlook
2.4 Therapy Class Outlook
2.5 Distribution Channel Outlook
2.6 Regional Outlook
Chapter 3 Global Orphan Drug Market Trend Analysis
3.1. Market Introduction
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on the Orphan Drug Market
3.4 Metric Data on Industry
3.5 Market Dynamic
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.5.4 Industry Opportunities
3.6 Porter’s Five Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Substitution Threat
3.6.4 Threat from New Entrant
3.7 Market Entry Strategies
Chapter 4 Orphan Drug Market: Drug Type Trend Analysis
4.1 Drug Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
4.2 Biological
4.2.1 Market Estimates & Forecast Analysis of Biological Segment, By Region, 2022-2028 (USD Billion)
4.3 Non-Biological
4.3.1 Market Estimates & Forecast Analysis of Non-Biological Markets Segment, By Region, 2022-2028 (USD Billion)
Chapter 5 Orphan Drug Market: Disease Type Trend Analysis
5.1 Disease Type: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
5.2 Oncologic Disease
5.2.1 Market Estimates & Forecast Analysis of Oncologic Disease Segment, By Region, 2022-2028 (USD Billion)
5.3 Metabolic Diseases
5.3.1 Market Estimates & Forecast Analysis of Metabolic Diseases Segment, By Region, 2022-2028 (USD Billion)
5.4 Hematologic and Immunologic Diseases
5.4.1 Market Estimates & Forecast Analysis of Hematologic and Immunologic Diseases Segment, By Region, 2022-2028 (USD Billion)
5.5 Infectious Diseases
5.5.1 Market Estimates & Forecast Analysis of Infectious Diseases Segment, By Region, 2022-2028 (USD Billion)
5.6 Others
5.6.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2022-2028 (USD Billion)
Chapter 6 Orphan Drug Market: Therapy Class Trend Analysis
6.1 Therapy Class: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
6.2 Oncology
6.2.1 Market Estimates & Forecast Analysis of Oncology Segment, By Region, 2022-2028 (USD Billion)
6.3 Hematology
6.3.1 Market Estimates & Forecast Analysis of Hematology Segment, By Region, 2022-2028 (USD Billion)
6.4 Neurology
6.4.1 Market Estimates & Forecast Analysis of Neurology Segment, By Region, 2022-2028 (USD Billion)
6.5 Others
6.5.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2022-2028 (USD Billion)
Chapter 7 Orphan Drug Market: Distribution Channel Trend Analysis
7.1 Distribution Channel: Historic Data vs. Forecast Data Analysis, 2022 vs. 2028
7.2 Hospital Pharmacy
7.2.1 Market Estimates & Forecast Analysis of Hospital Pharmacy Segment, By Region, 2022-2028 (USD Billion)
7.3 Retail Pharmacy
7.3.1 Market Estimates & Forecast Analysis of Retail Pharmacy Segment, By Region, 2022-2028 (USD Billion)
7.4 Online Sales
7.4.1 Market Estimates & Forecast Analysis of Online Sales Segment, By Region, 2022-2028 (USD Billion)
7.5 Others
7.5.1 Market Estimates & Forecast Analysis of Others Segment, By Region, 2022-2028 (USD Billion)
Chapter 9 Orphan Drug Market, By Region
8.1 Regional Outlook
8.2 North America
8.2.1 Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)
8.2.2 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.2.3 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.2.4 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.2.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.2.6 U.S.
8.2.6.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.2.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.2.6.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.2.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.2.7 Canada
8.2.7.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.2.7.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.2.7.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.2.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.2.8 Mexico
8.2.8.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028 (USD Billion)
8.2.8.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028 (USD Billion)
8.2.8.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028 (USD Billion)
8.2.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3 Europe
8.3.1 Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)
8.3.2 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.3 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.4 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.6 Germany
8.3.6.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.6.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.7 UK
8.3.7.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.7.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.7.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.8 France
8.3.8.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.8.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.8.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.9 Russia
8.3.9.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.9.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.9.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.9.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.10 Italy
8.3.10.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.10.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.10.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.10.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.11 Spain
8.3.11.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.3.11.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.3.11.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.3.11.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.3.12 Rest of Europe
8.3.12.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028 (USD Billion)
8.3.12.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028 (USD Billion)
8.3.12.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028 (USD Billion)
8.3.12.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4 Asia Pacific
8.4.1 Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)
8.4.2 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.4.3 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.4.4 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.4.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4.6 China
8.4.6.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.4.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.4.6.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.4.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4.7 India
8.4.7.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.4.7.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.4.7.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.4.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4.8 Japan
8.4.8.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.4.8.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.4.8.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.4.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4.9 Australia
8.4.9.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.4.9.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.4.9.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.4.9.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4.10 South Korea
8.4.10.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.4.10.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.4.10.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.4.10.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.4.11 Rest of Asia Pacific
8.4.11.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028 (USD Billion)
8.4.11.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028 (USD Billion)
8.4.11.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028 (USD Billion)
8.4.11.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.5 Central & South America
8.5.1 Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)
8.5.2 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.5.3 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.5.4 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.5.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.5.6 Brazil
8.5.6.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.5.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.5.6.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.5.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.5.7 Rest of Central & South America
8.5.7.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.5.7.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.5.7.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.5.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.6 Middle East & Africa
8.6.1 Market Estimates & Forecast Analysis, By Country 2022-2028(USD Billion)
8.6.2 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.6.3 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.6.4 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.6.5 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.6.6 Saudi Arabia
8.6.6.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.6.6.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.6.6.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.6.6.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.6.7 United Arab Emirates
8.6.7.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.6.7.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.6.7.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.6.7.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.6.8 South Africa
8.6.8.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028(USD Billion)
8.6.8.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028(USD Billion)
8.6.8.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028(USD Billion)
8.6.8.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
8.6.9 Rest of Middle East & Africa
8.6.9.1 Market Estimates & Forecast Analysis, By Drug Type, 2022-2028 (USD Billion)
8.6.9.2 Market Estimates & Forecast Analysis, By Disease Type, 2022-2028 (USD Billion)
8.6.9.3 Market Estimates & Forecast Analysis, By Therapy Class, 2022-2028 (USD Billion)
8.6.9.4 Market Estimates & Forecast Analysis, By Distribution Channel, 2022-2028(USD Billion)
Chapter 9 Competitive Analysis
9.1 Key Global Players, Recent Developments & their Impact on the Industry
9.2 Four Quadrant Competitor Positioning Matrix
9.2.1 Key Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Market Challengers
9.3 Vendor Landscape Analysis
9.4 Distribution Channel Landscape Analysis
9.5 Company Market Share Analysis, 2022
Chapter 10 Company Profile Analysis
10.1 Amgen Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Strategic Initiatives
10.1.4 Drug Type Benchmarking
10.2 Bayer AG
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Strategic Initiatives
10.2.4 Drug Type Benchmarking
10.3 F. Hoffmann-La Roche Ltd
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Strategic Initiatives
10.3.4 Drug Type Benchmarking
10.4 Alexion Pharmaceutical Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Strategic Initiatives
10.4.4 Drug Type Benchmarking
10.5 Novo Nordisk A/S
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Strategic Initiatives
10.5.4 Drug Type Benchmarking
10.6 Novartis AG
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Strategic Initiatives
10.6.4 Drug Type Benchmarking
10.7 Bristol-Myers Squibb Company
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Strategic Initiatives
10.7.4 Drug Type Benchmarking
10.8 AstraZeneca
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Strategic Initiatives
10.8.4 Drug Type Benchmarking
10.9 Daiichi Sankyo Company
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Strategic Initiatives
10.9.4 Drug Type Benchmarking
10.10 GlaxoSmithKline plc
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Strategic Initiatives
10.10.4 Drug Type Benchmarking
10.11 Other Companies
10.11.1 Company Overview
10.11.2 Financial Analysis
10.11.3 Strategic Initiatives
10.11.4 Drug Type Benchmarking
List of Tables
1 Technological Advancements In Orphan Drug Market
2 Global Orphan Drug Market: Key Market Drivers
3 Global Orphan Drug Market: Key Market Challenges
4 Global Orphan Drug Market: Key Market Opportunities
5 Global Orphan Drug Market: Key Market Restraints
6 Global Orphan Drug Market Estimates & Forecast Analysis, 2022-2028 (USD Billion)
7 Global Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
8 Biological: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
9 Non-Biological: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
10 Global Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
11 Oncologic Diseases: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
12 Metabolic Diseases: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
13 Hematologic and Immunologic Diseases: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
14 Infectious Diseases: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
15 Others: Global Drug Market, By Region, 2022-2028 (USD Billion)
16 Global Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
17 Oncology: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
18 Hematology: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
19 Neurology: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
20 Others: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
21 Global Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
22 Hospital Pharmacy: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
23 Retail Pharmacy: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
24 Online Sales: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
25 Others: Global Orphan Drug Markey, By Region, 2022-2028 (USD billion)
26 Regional Analysis: Global Orphan Drug Market, By Region, 2022-2028 (USD Billion)
27 North America: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
28 North America: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
29 North America: Orphan Drug Market, By Therapy Class , 2022-2028 (USD Billion)
30 North America: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
31 North America: Orphan Drug Market, By Country, 2022-2028 (USD Billion)
32 U.S: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
33 U.S: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
34 U.S: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
35 U.S: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
36 Canada: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
37 Canada: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
38 Canada: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
39 Canada: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
40 Mexico: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
41 Mexico: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
42 Mexico: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
43 Mexico: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
44 Europe: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
45 Europe: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
46 Europe: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
47 Europe: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
48 Germany: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
49 Germany: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
50 Germany: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
51 Germany: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
52 UK: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
53 UK: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
54 UK: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
55 UK: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
56 France: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
57 France: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
58 France: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
59 France: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
60 Italy: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
61 Italy: Orphan Drug Market, By T Disease Type , 2022-2028 (USD Billion)
62 Italy: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
63 ltaly: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
64 Spain: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
65 Spain: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
66 Spain: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
67 Spain: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
68 Rest Of Europe: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
69 Rest Of Europe: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
70 Rest Of Europe: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
71 Rest of Europe: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
72 Asia Pacific: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
73 Asia Pacific: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
74 Asia Pacific: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
75 Asia Pacific: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
76 Asia Pacific: Orphan Drug Market, By Country, 2022-2028 (USD Billion)
77 China: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
78 China: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
79 China: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
80 China: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
81 India: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
82 India: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
83 India: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
84 India: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
85 Japan: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
86 Japan: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
87 Japan: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
88 Japan: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
89 South Korea: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
90 South Korea: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
91 South Korea: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
92 South Korea: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
93 Middle East & Africa: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
94 Middle East & Africa: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
95 Middle East & Africa: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
96 Middle East & Africa: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
97 Middle East & Africa: Orphan Drug Market, By Country, 2022-2028 (USD Billion)
98 Saudi Arabia: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
99 Saudi Arabia: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
100 Saudi Arabia: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
101 Saudi Arabia: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
102 UAE: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
103 UAE: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
104 UAE: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
105 UAE: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
106 Central & South America: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
107 Central & South America: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
108 Central & South America: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
109 Central & South America: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
110 Central & South America: Orphan Drug Market, By Country, 2022-2028 (USD Billion)
111 Brazil: Orphan Drug Market, By Drug Type, 2022-2028 (USD Billion)
112 Brazil: Orphan Drug Market, By Disease Type, 2022-2028 (USD Billion)
113 Brazil: Orphan Drug Market, By Therapy Class, 2022-2028 (USD Billion)
114 Brazil: Orphan Drug Market, By Distribution Channel, 2022-2028 (USD Billion)
115 Amgen Inc.: Drug Types Offered
116 Bayer AG: Drug Types Offered
117 F. Hoffmann-La Roche Ltd: Drug Types Offered
118 Alexion Pharmaceutical Inc.: Drug Types Offered
119 Novo Nordisk A/S: Drug Types Offered
120 Novartis AG: Drug Types Offered
121 Bristol-Myers Squibb Company: Drug Types Offered
122 AstraZeneca: Drug Types Offered
123 Daiichi Sankyo Company: Drug Types Offered
124 GlaxoSmithKline plc: Drug Types Offered
125 Analog Devices, Inc: Drug Types Offered
126 Other Companies: Drug Types Offered
List of Figures
1. Global Orphan Drug Market Segmentation & Research Scope
2. Primary Research Partners and Local Informers
3. Primary Research Process
4. Primary Research Approaches
5. Primary Research Responses
6. Global Orphan Drug Market: Penetration & Growth Prospect Mapping
7. Global Orphan Drug Market: Value Chain Analysis
8. Global Orphan Drug Market Drivers
9. Global Orphan Drug Market Restraints
10. Global Orphan Drug Market Opportunities
11. Global Orphan Drug Market Challenges
12. Key Orphan Drug Market Manufacturer Analysis
13. Global Orphan Drug Market: Porter’s Five Forces Analysis
14. PESTLE Analysis & Impact Analysis
15. Amgen Inc.: Company Snapshot
16. Amgen Inc.: Swot Analysis
17. Bayer AG: Company Snapshot
18. Bayer AG: Swot Analysis
19. F. Hoffmann-La Roche Ltd: Company Snapshot
20. F. Hoffmann-La Roche Ltd: Swot Analysis
21. Alexion Pharmaceutical Inc.: Company Snapshot
22. Alexion Pharmaceutical Inc.: Swot Analysis
23. Novo Nordisk A/S: Company Snapshot
24. Novo Nordisk A/S: Swot Analysis
25. Novartis AG: Company Snapshot
26. Novartis AG: Swot Analysis
27. Bristol-Myers Squibb Company: Company Snapshot
28. Bristol-Myers Squibb Company: Swot Analysis
29. ASTRAZENECA: Company Snapshot
30. ASTRAZENECA: Swot Analysis
31. Daiichi Sankyo Company: Company Snapshot
32. Daiichi Sankyo Company: Swot Analysis
33. Enchandia AB Software: Company Snapshot
34. Enchandia AB Software: Swot Analysis
35. GlaxoSmithKline plc: Company Snapshot
36. GlaxoSmithKline plc: Swot Analysis
37. Analog Devices, Inc: Company Snapshot
38. Analog Devices, Inc: Swot Analysis
39. Other Companies: Company Snapshot
40. Other Companies: Swot Analysis
The Global Orphan Drugs Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Orphan Drugs Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
